In the heart, this can manifest as reduced contractility and impaired cardiac function, while in the brain, it may contribute to neuronal dysfunction and cognitive decline
When administered, semaglutide binds to GLP-1 receptors in the pancreas, stimulating insulin secretion in a glucose-dependent manner
When BCBS covers Zepbound, typical PA requirements include: BMI 30 or 27 with a comorbidity (hypertension, type 2 diabetes, high cholesterol, or OSA), 6 months of documented lifestyle modification (diet and exercise program), and sometimes step therapy requiring trial of other weight loss medications first
Meal timing influences protein utilization
Generally, adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition like high blood pressure or type 2 diabetes